75A50126C00005
Definitive Contract
Overview
Government Description
The purpose of this award is to advance the development of isola's nebulization therapy, a medical countermeasure designed to prevent and treat pulmonary foam the inhalation of chemical agents causes.
Awardee
Awarding / Funding Agency
Place of Performance
Minneapolis, MN 55410 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Est. Average FTE
14
Related Opportunity
EZBAA22100SOL00003
Isola Therapeutics was awarded
Definitive Contract 75A50126C00005 (75A501-26-C-00005)
for Development of Isola's Nebulization Therapy Pulmonary Foam Inhalation
worth up to $7,485,417
by the HHS Office of the Assistant Secretary for Preparedness and Response
in May 2026.
The contract
has a duration of 2 years 5 months and
was awarded
full & open
with
NAICS 541715 and
PSC AN13
via basic research acquisition procedures with 1 bid received.
Status
(Open)
Last Modified 4/27/26
Period of Performance
5/1/26
Start Date
10/31/28
Current End Date
10/31/28
Potential End Date
Obligations
$7.5M
Total Obligated
$7.5M
Current Award
$7.5M
Potential Award
Award Hierarchy
Definitive Contract
75A50126C00005
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75A50126C00005
Competition
Number of Bidders
1
Solicitation Procedures
Basic Research
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
M3QDM72NME75
Awardee CAGE
890E6
Agency Detail
Awarding Office
75A501 BARDA - ASPR / DAAPPO / BARDA DCMA
Funding Office
75A501
Created By
hhsveronicastroud
Last Modified By
hhsrichard_hall
Approved By
hhsrichard_hall
Legislative
Legislative Mandates
None Applicable
Performance District
MN-05
Senators
Amy Klobuchar
Tina Smith
Tina Smith
Representative
Ilhan Omar
Modified: 4/27/26